Soliton Selects RESONIC as Brand Name for FDA-Cleared Rapid Acoustic Pulse Device
The initial launch of the RESONIC brand for tattoo and cellulite indications is expected in Q2 of 2021.
Tag: RESONIC
All
LatestSorry, No Posts Found
All
Latest
FDA Extends Review of Opzelura for Pediatric Atopic Dermatitis
Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.
